ABEO — ABEONA THERAPEUTICS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About ABEONA THERAPEUTICS INC (ABEO)
ABEONA THERAPEUTICS INC (ABEO) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $2M. Across recent filings, tracked investors recorded 3 new positions, 1 increased, 1 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ABEO
How many top investors track ABEO
Only 2 tracked investors report this position.
ABEO Ownership Composition
How ABEONA THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.
- Other100.0%
Tracked investors reporting ABEO
- Izzy EnglanderMar 31, 2026Millennium ManagementShares425.4KValue$1.9M% Portfolio0.00%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares288KValue$1.3M% Portfolio0.00%
Recent activity
- $1.8MFeb 17, 2026
- $1.9MMay 15, 2026
- Increased$1.3M(7.03%)May 15, 2026
- Reduced$1.4M(-20.11%)Feb 17, 2026
- New$1.8MNov 14, 2025
Frequently asked questions
- How many institutional investors hold ABEO?
- 2 tracked institutional investors disclosed a position in ABEO (ABEONA THERAPEUTICS INC) in their most recent 13F filing.
- Who is the largest institutional holder of ABEO?
- Izzy Englander, Millennium Management, holds the largest disclosed position in ABEO, valued at $2M.
- Did institutional ownership of ABEO increase or decrease?
- Across recent 13F filings, tracked investors recorded 3 new positions, 1 increased, 1 reduced, and 0 fully exited ABEO.
- Where does this ABEO ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.